These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2284248)

  • 21. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
    Barone P; Braun AR; Chase TN
    Clin Neuropharmacol; 1986; 9 Suppl 4():128-30. PubMed ID: 2952266
    [No Abstract]   [Full Text] [Related]  

  • 23. Neurobiology of D1 dopamine receptors after neonatal-6-OHDA treatment: relevance to Lesch-Nyhan disease.
    Breese GR; Mueller RA; Napier TC; Duncan GE
    Adv Exp Med Biol; 1986; 204():197-215. PubMed ID: 2947429
    [No Abstract]   [Full Text] [Related]  

  • 24. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
    O'Boyle KM; Waddington JL
    Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Pharmacol Biochem Behav; 1989 Dec; 34(4):895-7. PubMed ID: 2533692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target size of dopamine D-1 receptors in rat corpus striatum estimated by binding of the benzazepine 3H-SCH 23390.
    Gredal O; Nielsen M; Hyttel J
    Pharmacol Toxicol; 1987 Apr; 60(4):255-7. PubMed ID: 2954035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of the enantiomers of SK&F 83566 as specific and stereoselective antagonists at the striatal D-1 dopamine receptor: comparisons with the D-2 enantioselectivity of Ro 22-1319.
    O'Boyle KM; Waddington JL
    Eur J Pharmacol; 1984 Oct; 106(1):219-20. PubMed ID: 6241567
    [No Abstract]   [Full Text] [Related]  

  • 29. Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
    Cincotta M; de Vries DJ; Beart PM
    Neurosci Lett; 1985 Oct; 61(1-2):85-9. PubMed ID: 2867505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular studies on the dopamine-induced firing inhibition of neostriatal neurons in vitro: evidence for D1 receptor involvement.
    Calabresi P; Mercuri N; Stanzione P; Stefani A; Bernardi G
    Neuroscience; 1987 Mar; 20(3):757-71. PubMed ID: 2955246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. D-1 and D-2 receptor manipulation in Cebus monkeys: implication for extrapyramidal syndromes in humans.
    Gerlach J; Casey D; Kistrup K
    Clin Neuropharmacol; 1986; 9 Suppl 4():131-3. PubMed ID: 2952267
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
    Gredal O; Nielsen M
    J Neurochem; 1987 Feb; 48(2):370-5. PubMed ID: 3491877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformational analysis and structure-activity relationships of selective dopamine D-1 receptor agonists and antagonists of the benzazepine series.
    Pettersson I; Liljefors T; Bøgesø K
    J Med Chem; 1990 Aug; 33(8):2197-204. PubMed ID: 1973733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
    Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
    Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
    Srivastava LK; Ross GM; Bajwa SB; Mishra RK
    Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of D1-dopamine receptor in chicken embryo retina with [125I]SCH 23982.
    Agui T; Chase TN; Kebabian JW
    Brain Res; 1988 Jun; 452(1-2):49-56. PubMed ID: 2969765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.